Latest News & Updates

Breaking News

  • 2 hours ago

  • Pharma Now Editorial Team

Centrum Adults 50+ Reformulated With Cognitive Health Claims
Breaking News
FDA Clears Third Oral SERD, Reshaping Oncology Manufacturing

Pharma Now Editorial Team

Other trending news you may like to read

Centrum Adults 50+ Reformulated With Cognitive Health Claims

Centrum relaunches Adults 50+ multivitamin in Canada with cognitive health claims tied to Harvard-affiliated clinical trial data.

Pharma Now Editorial Team

Pharma Now

FDA Clears Third Oral SERD, Reshaping Oncology Manufacturing

FDA approves Pfizer and Arvinas's vepdegestrant as Veppanu, the third oral SERD cleared for the US breast cancer market.

Pharma Now Editorial Team

Pharma Now

Chinese Insulin Clears FDA Interchangeable Bar, Reshaping US Supply

Sunshine Lake Pharma wins FDA interchangeable biosimilar status for insulin, entering a US market long held by three multinationals.

Pharma Now Editorial Team

Pharma Now

Health Canada Clears Aurobindo Bevacizumab Biosimilar

Aurobindo Pharma wins Health Canada approval for a bevacizumab biosimilar, entering the Canadian oncology market against Roche's Avastin.

Pharma Now Editorial Team

Pharma Now